This part of our website is currently under development. Please check back with us later. Thanks for your patience and interest.
Drug Labeling Session Was Held in Russia
20 March 2019
ACC: BMS, Pfizer's Eliquis tops warfarin in high-risk afib subgroup
Patient Input and Patient Preference Studies
Patient Support Programs: Cost, Benefit, and Resourcing
19 March 2019